FI105157B - Menetelmä terapeuttisen systeemin valmistamiseksi lääkeaineiden antamiseksi hidastetusti ja säädellysti ihon tai limakalvojen lävitse - Google Patents
Menetelmä terapeuttisen systeemin valmistamiseksi lääkeaineiden antamiseksi hidastetusti ja säädellysti ihon tai limakalvojen lävitse Download PDFInfo
- Publication number
- FI105157B FI105157B FI900740A FI900740A FI105157B FI 105157 B FI105157 B FI 105157B FI 900740 A FI900740 A FI 900740A FI 900740 A FI900740 A FI 900740A FI 105157 B FI105157 B FI 105157B
- Authority
- FI
- Finland
- Prior art keywords
- drug
- excipient
- drugs
- process according
- reservoir
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 10
- 230000002459 sustained effect Effects 0.000 title claims abstract 3
- 239000003814 drug Substances 0.000 title claims description 80
- 229940079593 drug Drugs 0.000 title claims description 73
- 238000000034 method Methods 0.000 title claims description 21
- 210000004400 mucous membrane Anatomy 0.000 title claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 17
- 238000009792 diffusion process Methods 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- -1 repterolol Chemical compound 0.000 claims description 7
- 239000000150 Sympathomimetic Substances 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 6
- 239000002830 appetite depressant Substances 0.000 claims description 4
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 claims description 4
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 claims description 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 3
- 239000002876 beta blocker Substances 0.000 claims description 3
- 229940097320 beta blocking agent Drugs 0.000 claims description 3
- 229960002715 nicotine Drugs 0.000 claims description 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 3
- 229940127230 sympathomimetic drug Drugs 0.000 claims description 3
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 claims description 2
- CEMAWMOMDPGJMB-UHFFFAOYSA-N (+-)-Oxprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1OCC=C CEMAWMOMDPGJMB-UHFFFAOYSA-N 0.000 claims description 2
- NXWGWUVGUSFQJC-GFCCVEGCSA-N (2r)-1-[(2-methyl-1h-indol-4-yl)oxy]-3-(propan-2-ylamino)propan-2-ol Chemical compound CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=C(C)N2 NXWGWUVGUSFQJC-GFCCVEGCSA-N 0.000 claims description 2
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 claims description 2
- PTKSEFOSCHHMPD-SNVBAGLBSA-N 2-amino-n-[(2s)-2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide Chemical compound COC1=CC=C(OC)C([C@H](O)CNC(=O)CN)=C1 PTKSEFOSCHHMPD-SNVBAGLBSA-N 0.000 claims description 2
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims description 2
- 229960004162 bamethan Drugs 0.000 claims description 2
- RDUHXGIIUDVSHR-UHFFFAOYSA-N bamethan Chemical compound CCCCNCC(O)C1=CC=C(O)C=C1 RDUHXGIIUDVSHR-UHFFFAOYSA-N 0.000 claims description 2
- 229960004634 carazolol Drugs 0.000 claims description 2
- BQXQGZPYHWWCEB-UHFFFAOYSA-N carazolol Chemical compound N1C2=CC=CC=C2C2=C1C=CC=C2OCC(O)CNC(C)C BQXQGZPYHWWCEB-UHFFFAOYSA-N 0.000 claims description 2
- 229960003609 cathine Drugs 0.000 claims description 2
- DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical group C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 claims description 2
- 229960001117 clenbuterol Drugs 0.000 claims description 2
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 claims description 2
- 229960004890 diethylpropion Drugs 0.000 claims description 2
- XXEPPPIWZFICOJ-UHFFFAOYSA-N diethylpropion Chemical compound CCN(CC)C(C)C(=O)C1=CC=CC=C1 XXEPPPIWZFICOJ-UHFFFAOYSA-N 0.000 claims description 2
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 claims description 2
- 229960001582 fenfluramine Drugs 0.000 claims description 2
- 229960001022 fenoterol Drugs 0.000 claims description 2
- LSLYOANBFKQKPT-UHFFFAOYSA-N fenoterol Chemical compound C=1C(O)=CC(O)=CC=1C(O)CNC(C)CC1=CC=C(O)C=C1 LSLYOANBFKQKPT-UHFFFAOYSA-N 0.000 claims description 2
- 229960000708 hexoprenaline Drugs 0.000 claims description 2
- OXLZNBCNGJWPRV-UHFFFAOYSA-N hexoprenaline Chemical compound C=1C=C(O)C(O)=CC=1C(O)CNCCCCCCNCC(O)C1=CC=C(O)C(O)=C1 OXLZNBCNGJWPRV-UHFFFAOYSA-N 0.000 claims description 2
- 229960001468 mefenorex Drugs 0.000 claims description 2
- XXVROGAVTTXONC-UHFFFAOYSA-N mefenorex Chemical compound ClCCCNC(C)CC1=CC=CC=C1 XXVROGAVTTXONC-UHFFFAOYSA-N 0.000 claims description 2
- 229960003134 mepindolol Drugs 0.000 claims description 2
- 229960001094 midodrine Drugs 0.000 claims description 2
- 229960004255 nadolol Drugs 0.000 claims description 2
- VWPOSFSPZNDTMJ-UCWKZMIHSA-N nadolol Chemical compound C1[C@@H](O)[C@@H](O)CC2=C1C=CC=C2OCC(O)CNC(C)(C)C VWPOSFSPZNDTMJ-UCWKZMIHSA-N 0.000 claims description 2
- 229960003684 oxedrine Drugs 0.000 claims description 2
- 229960004570 oxprenolol Drugs 0.000 claims description 2
- 229960002035 penbutolol Drugs 0.000 claims description 2
- KQXKVJAGOJTNJS-HNNXBMFYSA-N penbutolol Chemical compound CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1 KQXKVJAGOJTNJS-HNNXBMFYSA-N 0.000 claims description 2
- 229960002508 pindolol Drugs 0.000 claims description 2
- PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 claims description 2
- 229960003712 propranolol Drugs 0.000 claims description 2
- JCRIVQIOJSSCQD-UHFFFAOYSA-N propylhexedrine Chemical compound CNC(C)CC1CCCCC1 JCRIVQIOJSSCQD-UHFFFAOYSA-N 0.000 claims description 2
- 229960000786 propylhexedrine Drugs 0.000 claims description 2
- 229960002052 salbutamol Drugs 0.000 claims description 2
- 229960002370 sotalol Drugs 0.000 claims description 2
- ZBMZVLHSJCTVON-UHFFFAOYSA-N sotalol Chemical compound CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 ZBMZVLHSJCTVON-UHFFFAOYSA-N 0.000 claims description 2
- 229960004605 timolol Drugs 0.000 claims description 2
- 239000002585 base Substances 0.000 claims 3
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 claims 1
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 claims 1
- QHGUCRYDKWKLMG-QMMMGPOBSA-N (R)-octopamine Chemical compound NC[C@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-QMMMGPOBSA-N 0.000 claims 1
- WXFIGDLSSYIKKV-RCOVLWMOSA-N L-Metaraminol Chemical compound C[C@H](N)[C@H](O)C1=CC=CC(O)=C1 WXFIGDLSSYIKKV-RCOVLWMOSA-N 0.000 claims 1
- QHGUCRYDKWKLMG-MRVPVSSYSA-N Octopamine Natural products NC[C@@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-MRVPVSSYSA-N 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- 229960002274 atenolol Drugs 0.000 claims 1
- 229960004324 betaxolol Drugs 0.000 claims 1
- CHDPSNLJFOQTRK-UHFFFAOYSA-N betaxolol hydrochloride Chemical compound [Cl-].C1=CC(OCC(O)C[NH2+]C(C)C)=CC=C1CCOCC1CC1 CHDPSNLJFOQTRK-UHFFFAOYSA-N 0.000 claims 1
- 229960000330 bupranolol Drugs 0.000 claims 1
- HQIRNZOQPUAHHV-UHFFFAOYSA-N bupranolol Chemical compound CC1=CC=C(Cl)C(OCC(O)CNC(C)(C)C)=C1 HQIRNZOQPUAHHV-UHFFFAOYSA-N 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 229960003663 metaraminol Drugs 0.000 claims 1
- 229960001576 octopamine Drugs 0.000 claims 1
- 125000003367 polycyclic group Chemical group 0.000 claims 1
- 229960000195 terbutaline Drugs 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 7
- 239000013543 active substance Substances 0.000 abstract 7
- 239000010410 layer Substances 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 14
- 210000004379 membrane Anatomy 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229940064707 sympathomimetics Drugs 0.000 description 3
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000037368 penetrate the skin Effects 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- VSKJLJHPAFKHBX-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 VSKJLJHPAFKHBX-UHFFFAOYSA-N 0.000 description 1
- BMUKKTUHUDJSNZ-UHFFFAOYSA-N 4-[1-hydroxy-2-(1-phenoxypropan-2-ylamino)propyl]phenol Chemical compound C=1C=C(O)C=CC=1C(O)C(C)NC(C)COC1=CC=CC=C1 BMUKKTUHUDJSNZ-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920003149 Eudragit® E 100 Polymers 0.000 description 1
- 229920003139 Eudragit® L 100 Polymers 0.000 description 1
- 229920003141 Eudragit® S 100 Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 238000010669 acid-base reaction Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229960002213 alprenolol Drugs 0.000 description 1
- PAZJSJFMUHDSTF-UHFFFAOYSA-N alprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1CC=C PAZJSJFMUHDSTF-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- NEDGUIRITORSKL-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;2-(dimethylamino)ethyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.CCCCOC(=O)C(C)=C.CN(C)CCOC(=O)C(C)=C NEDGUIRITORSKL-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 229960004819 isoxsuprine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- QHGUCRYDKWKLMG-UHFFFAOYSA-N octopamine Chemical compound NCC(O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960002720 reproterol Drugs 0.000 description 1
- WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 229940100640 transdermal system Drugs 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Steroid Compounds (AREA)
- Furan Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3905050 | 1989-02-18 | ||
| DE3905050A DE3905050A1 (de) | 1989-02-18 | 1989-02-18 | Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI900740A0 FI900740A0 (fi) | 1990-02-14 |
| FI105157B true FI105157B (fi) | 2000-06-30 |
Family
ID=6374442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI900740A FI105157B (fi) | 1989-02-18 | 1990-02-14 | Menetelmä terapeuttisen systeemin valmistamiseksi lääkeaineiden antamiseksi hidastetusti ja säädellysti ihon tai limakalvojen lävitse |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5466466A (enExample) |
| EP (1) | EP0384266B1 (enExample) |
| JP (1) | JP2552190B2 (enExample) |
| AT (1) | ATE108680T1 (enExample) |
| AU (1) | AU627268B2 (enExample) |
| CA (1) | CA2010218C (enExample) |
| DD (1) | DD291928A5 (enExample) |
| DE (2) | DE3905050A1 (enExample) |
| DK (1) | DK0384266T3 (enExample) |
| ES (1) | ES2060825T3 (enExample) |
| FI (1) | FI105157B (enExample) |
| IE (1) | IE66739B1 (enExample) |
| NO (1) | NO303207B1 (enExample) |
| PT (1) | PT93191B (enExample) |
| ZA (1) | ZA901183B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL105073A0 (en) † | 1992-03-17 | 1993-07-08 | Becton Dickinson Co | User activated iontophoretic device and method for using same |
| US5730721A (en) | 1996-01-25 | 1998-03-24 | Vesture Corporation | Medical applicator and method |
| DE19653606A1 (de) * | 1996-12-20 | 1998-06-25 | Roehm Gmbh | Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher |
| US5912255A (en) * | 1998-02-27 | 1999-06-15 | Bussell; Letantia | Topical fluoroquinolone antibiotics combined with benzoyl peroxide |
| DE19814083C2 (de) | 1998-03-30 | 2002-02-07 | Lohmann Therapie Syst Lts | Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen |
| DE19814087A1 (de) | 1998-03-30 | 1999-10-14 | Lohmann Therapie Syst Lts | Feuchtigkeitsaktivierbares therapeutisches System |
| US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
| AU775149B2 (en) | 1999-10-21 | 2004-07-22 | Alcon Inc. | Sub-tenon drug delivery |
| ATE283013T1 (de) | 1999-10-21 | 2004-12-15 | Alcon Inc | Medikamentenzuführvorrichtung |
| US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
| US20060189552A1 (en) * | 2000-12-12 | 2006-08-24 | Mohan Vishnupad | Dispenser for dispensing three or more actives |
| US20020193321A1 (en) * | 2000-12-12 | 2002-12-19 | Mohan Vishnupad | Dual dispenser for aesthitically acceptable delivery of anhydrous skin treatment compositions |
| US7060732B2 (en) | 2000-12-12 | 2006-06-13 | Imaginative Research Associates, Inc. | Antibiotic/benzoyl peroxide dispenser |
| EP1387671A1 (en) | 2001-05-03 | 2004-02-11 | MASSACHUSETTS EYE & EAR INFIRMARY | Implantable drug delivery device and use thereof |
| MXPA03011609A (es) | 2001-07-23 | 2004-07-01 | Alcon Inc | Dispositivo de entrega de droga oftalmica. |
| AU2002319606B2 (en) * | 2001-07-23 | 2006-09-14 | Alcon, Inc. | Ophthalmic drug delivery device |
| CA2522592A1 (en) * | 2003-07-10 | 2005-02-03 | Alcon, Inc. | Ophthalmic drug delivery device |
| RU2356580C2 (ru) * | 2003-10-28 | 2009-05-27 | Новен Фармасьютикалз, Инк | Композиции и способы, обеспечивающие контролируемую потерю лекарственных средств и доставку в системах трансдермальной доставки лекарственных средств |
| US7662855B2 (en) * | 2004-05-11 | 2010-02-16 | Imaginative Research Associates, Inc. | Retinoid solutions and formulations made therefrom |
| US20060014834A1 (en) * | 2004-05-11 | 2006-01-19 | Mohan Vishnupad | Retinoid solutions and formulations made therefrom |
| DE102004062614B4 (de) * | 2004-12-24 | 2011-12-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung |
| US20080138388A1 (en) * | 2005-02-04 | 2008-06-12 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal Absorption Patch |
| US20100004156A1 (en) | 2005-07-27 | 2010-01-07 | Shalesh Kaushal | Small Compounds That Correct Protein Misfolding and Uses Thereof |
| CN101370505B (zh) | 2005-11-29 | 2012-03-21 | 史密丝克莱恩比彻姆公司 | 新生血管性眼病如黄斑变性、血管样纹、葡萄膜炎和黄斑水肿的治疗 |
| TWI498136B (zh) * | 2007-10-09 | 2015-09-01 | Alcon Res Ltd | 用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法 |
| TWI451862B (zh) * | 2007-10-09 | 2014-09-11 | Alcon Res Ltd | 用於眼睛注射的熱係數驅動藥丸尺寸 |
| DE102008013701A1 (de) | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
| US8632511B2 (en) | 2009-05-06 | 2014-01-21 | Alcon Research, Ltd. | Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device |
| IN2012DN00352A (enExample) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
| US20120232102A1 (en) | 2009-09-30 | 2012-09-13 | Chun-Fang Xu | Methods Of Administration And Treatment |
| US8177747B2 (en) | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
| CN103501770B (zh) | 2011-04-18 | 2015-04-29 | 久光制药株式会社 | 贴附剂的制造方法及贴附剂 |
| WO2012174064A1 (en) | 2011-06-14 | 2012-12-20 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
| EP2768307B1 (en) | 2011-10-19 | 2020-03-18 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
| BR112014012997A2 (pt) | 2011-11-30 | 2017-06-13 | Bikam Pharmaceuticals Inc | ligantes que se ligam à opsina, composições e métodos de uso |
| AU2012346537A1 (en) | 2011-12-01 | 2014-07-17 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405616A (en) | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
| US4756710A (en) * | 1985-04-05 | 1988-07-12 | Merck & Co., Inc. | pH-Mediated drug delivery system |
| EP0249343B1 (en) | 1986-06-13 | 1992-01-08 | Alza Corporation | Moisture activation of transdermal drug delivery system |
| EP0249475A3 (en) | 1986-06-13 | 1989-10-11 | Alza Corporation | Delayed percutaneous delivery |
| JPS6425717A (en) * | 1987-05-08 | 1989-01-27 | Eastman Kodak Co | Method and apparatus for preventing organic nitric acid ester resistance |
| US4781924A (en) * | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
-
1989
- 1989-02-18 DE DE3905050A patent/DE3905050A1/de active Granted
-
1990
- 1990-01-25 AU AU48770/90A patent/AU627268B2/en not_active Ceased
- 1990-02-13 AT AT90102770T patent/ATE108680T1/de active
- 1990-02-13 ES ES90102770T patent/ES2060825T3/es not_active Expired - Lifetime
- 1990-02-13 DE DE59006461T patent/DE59006461D1/de not_active Expired - Fee Related
- 1990-02-13 DK DK90102770.6T patent/DK0384266T3/da active
- 1990-02-13 EP EP90102770A patent/EP0384266B1/de not_active Expired - Lifetime
- 1990-02-14 JP JP2031657A patent/JP2552190B2/ja not_active Expired - Lifetime
- 1990-02-14 FI FI900740A patent/FI105157B/fi not_active IP Right Cessation
- 1990-02-16 DD DD90337919A patent/DD291928A5/de not_active IP Right Cessation
- 1990-02-16 PT PT93191A patent/PT93191B/pt active IP Right Grant
- 1990-02-16 CA CA002010218A patent/CA2010218C/en not_active Expired - Fee Related
- 1990-02-16 ZA ZA901183A patent/ZA901183B/xx unknown
- 1990-02-16 NO NO900748A patent/NO303207B1/no not_active IP Right Cessation
- 1990-02-16 IE IE58090A patent/IE66739B1/en not_active IP Right Cessation
-
1994
- 1994-04-20 US US08/230,448 patent/US5466466A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE59006461D1 (de) | 1994-08-25 |
| US5466466A (en) | 1995-11-14 |
| NO900748D0 (no) | 1990-02-16 |
| ZA901183B (en) | 1990-11-28 |
| CA2010218A1 (en) | 1990-08-18 |
| EP0384266B1 (de) | 1994-07-20 |
| JPH03197420A (ja) | 1991-08-28 |
| AU4877090A (en) | 1990-08-23 |
| JP2552190B2 (ja) | 1996-11-06 |
| ES2060825T3 (es) | 1994-12-01 |
| DD291928A5 (de) | 1991-07-18 |
| CA2010218C (en) | 1998-04-28 |
| PT93191B (pt) | 1998-01-30 |
| NO303207B1 (no) | 1998-06-15 |
| AU627268B2 (en) | 1992-08-20 |
| PT93191A (pt) | 1990-08-31 |
| NO900748L (no) | 1990-08-20 |
| EP0384266A3 (en) | 1990-11-22 |
| IE900580L (en) | 1990-08-18 |
| DE3905050A1 (de) | 1990-08-30 |
| IE66739B1 (en) | 1996-02-07 |
| EP0384266A2 (de) | 1990-08-29 |
| DK0384266T3 (da) | 1994-11-21 |
| ATE108680T1 (de) | 1994-08-15 |
| FI900740A0 (fi) | 1990-02-14 |
| DE3905050C2 (enExample) | 1991-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI105157B (fi) | Menetelmä terapeuttisen systeemin valmistamiseksi lääkeaineiden antamiseksi hidastetusti ja säädellysti ihon tai limakalvojen lävitse | |
| FI111338B (fi) | Menetelmä välineen valmistamiseksi vaikuttavien aineiden paikalliseen ja systeemiseen antoon iholle | |
| FI95539B (fi) | Transdermaalinen järjestelmä, sen valmistusmenetelmä ja käyttö | |
| FI89243B (fi) | Terapeutiskt system och foerfarande foer dess anstaellning | |
| US5284660A (en) | Delayed onset transdermal delivery device | |
| US5591767A (en) | Liquid reservoir transdermal patch for the administration of ketorolac | |
| US4031894A (en) | Bandage for transdermally administering scopolamine to prevent nausea | |
| US4262003A (en) | Method and therapeutic system for administering scopolamine transdermally | |
| US6224900B1 (en) | Sealing bag for a transdermal therapeutic system | |
| US5589498A (en) | Transdermal delivery of the active enantiomer of ketorolac | |
| RU2251413C2 (ru) | Трансдермальная терапевтическая система (ттс), содержащая толтеродин | |
| US6139868A (en) | Transdermal therapeutic system, its use and production process | |
| SK280996B6 (sk) | Náplasť ako transdermálny terapeutický systém, spôsob jej výroby a použitie | |
| JPH01135717A (ja) | 改良された薬物経皮供給デバイス | |
| AU5891999A (en) | Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder | |
| US5215751A (en) | Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (i) | |
| US6264977B1 (en) | Transdermal therapeutic system, its use and production process | |
| US6110488A (en) | Transdermal therapeutic system, its use and production process | |
| SK279357B6 (sk) | Transdermálny systém a jeho použitie | |
| ZA200500255B (en) | Improved transdermal delivery system | |
| US6117448A (en) | Transdermal therapeutic system, its use and production process | |
| WO1994008572A1 (en) | Delayed onset transdermal delivery device | |
| JPH10511972A (ja) | （ｓ）−３−メチル−５−（１−メチル−２−ピロリデニル）−イソオキサゾールまたはその製薬上受け入れられる塩類の一つの投与のための経皮性治療系 | |
| MXPA97005324A (en) | Transdermal therapeutic system for the supply of (s) -3-methyl-5- (1-methyl-2-pirrolidenyl) -isoxazole or any of its salts pharmaceutically ap |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: LTS LOHMANN THERAPIE-SYSTEME GMBH & CO. KG |